<html><head></head><body><div class="headers"><div style="font-size:20px; font-weight:bold; white-space: normal;"></div></div><table><thead><tr class="valign-top rowsep-1"><td colspan="2" rowspan="1" scope="col">&nbsp;</td><th class="align-left" scope="col">Oral semaglutide group&nbsp;</th><th class="align-left" scope="col">Placebo group&nbsp;</th><th class="align-left" scope="col">Total population&nbsp;</th></tr><tr><td colspan="2" scope="col" class="bold">n</td><th class="align-left" scope="col">163</th><th class="align-left" scope="col">161</th><th class="align-left" scope="col">324</th></tr></thead><tbody><tr class="valign-top"><td class="align-left bold" colspan="2">Age, years</td><td class="align-left">71 (8)</td><td class="align-left">70 (8)</td><td class="align-left">70 (8)</td></tr><tr class="valign-top"><td class="align-left bold" colspan="5">Sex</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Female</td><td class="align-left">80 (49%)</td><td class="align-left">88 (55%)</td><td class="align-left">168 (52%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Male</td><td class="align-left">83 (51%)</td><td class="align-left">73 (45%)</td><td class="align-left">156 (48%)</td></tr><tr class="valign-top"><td class="align-left bold" colspan="5">Race</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">White</td><td class="align-left">158 (97%)</td><td class="align-left">152 (94%)</td><td class="align-left">310 (96%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Black or African American</td><td class="align-left">4 (2%)</td><td class="align-left">9 (6%)</td><td class="align-left">13 (4%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Asian</td><td class="align-left">1 (1%)</td><td class="align-left">0</td><td class="align-left">1 (&lt;1%)</td></tr><tr class="valign-top"><td class="align-left bold" colspan="5">Ethnicity</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Hispanic or Latino</td><td class="align-left">7 (4%)</td><td class="align-left">14 (9%)</td><td class="align-left">21 (6%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Other</td><td class="align-left">156 (96%)</td><td class="align-left">147 (91%)</td><td class="align-left">303 (94%)</td></tr><tr><td colspan="5" class="bold">Other</td></tr><tr class="valign-top"><td class="align-left" colspan="2">Duration of diabetes, years</td><td class="align-left">141 (86)</td><td class="align-left">139 (74)</td><td class="align-left">140 (80)</td></tr><tr class="valign-top"><td class="align-left" colspan="2">Bodyweight, kg</td><td class="align-left">913 (178)</td><td class="align-left">904 (175)</td><td class="align-left">908 (176)</td></tr><tr class="valign-bottom"><td class="align-left" colspan="2">BMI, kg/m<sup>2</sup></td><td class="align-left">322 (54)</td><td class="align-left">326 (55)</td><td class="align-left">324 (54)</td></tr><tr class="valign-top"><td class="align-left" colspan="2">Waist circumference, cm</td><td class="align-left">1068 (139)</td><td class="align-left">1079 (128)</td><td class="align-left">1073 (133)</td></tr><tr class="valign-top"><td class="align-left" colspan="2">HbA<sub>1c</sub>, %</td><td class="align-left">80% (07)</td><td class="align-left">79% (07)</td><td class="align-left">80% (07)</td></tr><tr class="valign-top"><td class="align-left" colspan="2">HbA<sub>1c</sub>, mmol/mol</td><td class="align-left">64 (8)</td><td class="align-left">63 (8)</td><td class="align-left">64 (8)</td></tr><tr class="valign-top"><td class="align-left" colspan="2">Fasting plasma glucose, mmol/L</td><td class="align-left">91 (27)</td><td class="align-left">91 (28)</td><td class="align-left">91 (27)</td></tr><tr class="valign-bottom"><td class="align-left bold" colspan="2">eGFR, mL/min per 173 m<sup>2</sup></td><td class="align-left">47 (10)</td><td class="align-left">48 (10)</td><td class="align-left">48 (10)</td></tr><tr class="valign-bottom"><td colspan="2" rowspan="1">Stage 3A (45&lt;60 mL/min per 173 m<sup>2</sup>)</td><td class="align-left">99 (61%)</td><td class="align-left">97 (60%)</td><td class="align-left">196 (60%)</td></tr><tr class="valign-bottom"><td colspan="2" rowspan="1">Stage 3B (30&lt;45 mL/min per 173 m<sup>2</sup>)</td><td class="align-left">64 (39%)</td><td class="align-left">64 (40%)</td><td class="align-left">128 (40%)</td></tr><tr class="valign-top"><td class="align-left bold" colspan="2">Urinary albumin to creatinine ratio, mg/g</td><td class="align-left">192 (741149)</td><td class="align-left">141 (55908)</td><td class="align-left">160 (63998)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">&lt;30 mg/g</td><td class="align-left">96 (59%)</td><td class="align-left">105 (65%)</td><td class="align-left">201 (62%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">30300 mg/g</td><td class="align-left">44 (27%)</td><td class="align-left">25 (16%)</td><td class="align-left">69 (21%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">&gt;300 mg/g</td><td class="align-left">22 (13%)</td><td class="align-left">26 (16%)</td><td class="align-left">48 (15%)</td></tr><tr class="valign-top"><td colspan="2" rowspan="1">Unclassified</td><td class="align-left">1 (1%)</td><td class="align-left">5 (3%)</td><td class="align-left">6 (2%)</td></tr></tbody></table></body></html>